Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3350
+0.0250 (1.08%)
NASDAQ· Last Trade: Sep 16th, 11:57 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors